One of the recently rising rosacea treatments, botulinum toxin has attracted awareness for its prospective efficacy in offering approximately four months of symptomatic reduction. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone with the treatment of myofascial pain syndrome and ache from Persistent muscle spasm.